GKOS GLAUKOS Corp

  1. Stocks
  2. Healthcare
  3. NYSE: GKOS

Price (delayed)

$123.12

Market cap

$7.23B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.29

Enterprise value

$7.23B

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 57
Relative Valuation: Rel. Valuation: 9
Relative Profitability: Rel. Profitability: 21

Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery, ...

Highlights
The revenue has grown by 36% YoY and by 9% from the previous quarter
The company's gross profit rose by 12% QoQ and by 3.7% YoY
The gross margin has contracted by 24% YoY but it has grown by 3.4% from the previous quarter
The quick ratio has contracted by 18% YoY but it has grown by 16% from the previous quarter
GLAUKOS's net income has shrunk by 53% YoY
GLAUKOS's EPS has decreased by 43% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.glaukos.com
Peers: IART ICUI

Key stats

What are the main financial stats of GKOS

GKOS stock price

How has the GLAUKOS stock price performed over time
Intraday
8.34%
1 week
15.58%
1 month
-9.37%
1 year
35.36%
YTD
9.04%
QTD
14.36%

Financial performance

How have GLAUKOS's revenue and profit performed over time
Revenue
$551.35M
Gross profit
$317.65M
Operating income
-$198.78M
Net income
-$189.33M
Gross margin
57.6%
Net margin
-34.3%
GKOS's operating income has shrunk by 91% YoY
GLAUKOS's net income has shrunk by 53% YoY
The company's operating margin fell by 40% YoY but it rose by 8% QoQ
The revenue has grown by 36% YoY and by 9% from the previous quarter

Price vs fundamentals

How does GKOS's price correlate with its fundamentals

Growth

What is GLAUKOS's growth rate over time

Valuation

What is GLAUKOS stock price valuation
P/E
N/A
P/B
10.66
P/S
12.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.11
GLAUKOS's EPS has decreased by 43% YoY
The price to book (P/B) is 41% more than the 5-year quarterly average of 7.0 and 20% more than the last 4 quarters average of 8.2
GLAUKOS's equity has decreased by 12% YoY but it has increased by 2.3% QoQ
The revenue has grown by 36% YoY and by 9% from the previous quarter

Efficiency

How efficient is GLAUKOS business performance
The ROIC has dropped by 57% year-on-year
The return on assets has dropped by 53% year-on-year and by 3.1% since the previous quarter
The ROE has plunged by 53% YoY and by 4.3% from the previous quarter
GLAUKOS's ROS has decreased by 21% YoY but it has increased by 7% from the previous quarter

Dividends

What is GKOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GKOS.

Financial health

How did GLAUKOS financials performed over time
The quick ratio has contracted by 18% YoY but it has grown by 16% from the previous quarter
GKOS's current ratio is down by 16% year-on-year but it is up by 16% since the previous quarter
The debt is 85% lower than the equity
GLAUKOS's equity has decreased by 12% YoY but it has increased by 2.3% QoQ
The debt to equity has grown by 7% YoY but it has contracted by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.